| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Biotechnology
| Moderna is achieving significant breakthroughs in cancer vaccine development, particularly with its mRNA-based personalized vaccines for melanoma, which has garnered considerable optimism among investors and analysts. The potential for these therapies to transform cancer treatment could generate substantial market value, indicating a robust long-term outlook for the company's product pipeline. Additionally, the successful collaboration with Merck on personalized vaccines showcases innovative advancements in cancer care. However, competition and market uncertainties remain challenges in fully realizing this potential. |
| The price action of Moderna Inc (MRNA) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 9.5 is extremely bullish. The market sentiment at 3.9 is extremely bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. MRNA is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 4, and the negative at -0.1 on 2026-08-25. The forces of Stock Price Trend (9.5), Market Risk Appetite (5.4), Sentiment towards Fundamentals (4.4), Valuation Sentiment (2.3), Sector Price Trend (2), and Option Sentiment (1.5) will drive up the price. The forces of and Price Level Sentiment (-0.5) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| MRNA | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 | 0%(0.4%) | 159.14 | 25.31% | 98 | 75 | 86 | 13.98% | 10.2% | 9.5 | 0 | 1% | 2.5 | Long | 70% | 4.4 | 5.5 |
| 2026-08-24 | 0%(0.4%) | 139.62 | 26.14% | 93 | 72 | 0 | -3.7% | 8.98% | 9.5 | 0 | 1% | 2.5 | Long | 55% | 4.2 | 5 |
| 2026-08-23 | 0%(0.4%) | 9.5 | 0 | 2.5 | 4.3 | -1 | ||||||||||
| 2026-08-22 | 0%(0.4%) | 9.5 | 0 | 2.5 | 4.5 | -1 | ||||||||||
| 2026-08-21 | 0%(0.4%) | 144.98 | 23.28% | 104 | 75 | 0 | 8.75% | 10.68% | 9.5 | 0 | 1% | 2.5 | Long | 70% | 4.6 | 3 |
| 2026-08-20 | 1%(0.4%) | 133.32 | 22.16% | 105 | 73 | 0 | -23.55% | 10.88% | 9.5 | 0 | 1% | 2.5 | Long | 70% | 5.7 | 3.6 |
| 2026-08-19 | 2%(0.3%) | 174.38 | 14.63% | 158 | 94 | 0 | 176.97% | 19.41% | 9.5 | 0 | 1% | 2.5 | Wait | 50% | 6.4 | 6.8 |
| 2026-08-18 | 0%(0%) | 62.96 | 5.56% | 83 | 67 | 0 | -2.33% | 1% | 1.7 | 0 | 1% | 1.1 | Long | 65% | 4.4 | -1 |
| 2026-08-17 | 0%(0%) | 64.46 | 5.21% | 97 | 68 | 0 | 1.8% | 1.69% | 2.8 | 0 | 1% | 1.3 | Long | 70% | 4.4 | -1 |
| 2026-08-16 | 0%(0%) | 2.3 | 0 | 2.3 | 4.4 | -1 | ||||||||||
| Long is the preferred trading strategy with 70% chance of being right. Both trend sentiment and hourly trend are very strong. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| 2026-08-25 17:47:32 Investor sentiment regarding the stock may be optimistic, factoring in future growth from the new vaccine. |
| 2026-08-25 17:47:32 The potential for a multibillion-dollar market in cancer treatment is enticing for investors and may influence stock pricing. |
| 2026-08-25 17:47:32 The advancement of Moderna and Merck's personalized cancer vaccine represents significant innovation in cancer treatment. |
| 2026-08-25 17:16:31 Moderna's performance is contrasting with broader trends in the biotech sector, highlighting its unique position in the market. |
| 2026-08-25 17:16:31 Key trading signals and indicators such as Power Inflow alerts are influencing trading strategies around Moderna's stock. |
| 2026-08-25 17:16:31 Moderna is making strides in the development of its cancer vaccine, which is positively influencing investor sentiment. |
| 2026-08-25 17:16:31 Analysts are increasingly optimistic about Moderna, providing upgrades following positive news from clinical trials. |
| 2026-08-25 17:16:31 There is a significant positive movement in Moderna's stock price due to key trading signals and positive analyst ratings. |
| 2026-08-25 15:47:30 Investors may be pricing in much of the potential of Moderna's cancer vaccine, reflecting considerations around current stock valuation in light of future growth prospects. |
| 2026-08-25 15:47:30 The development of a personalized cancer vaccine by Moderna and Merck represents a significant advancement in cancer treatment that could create a multibillion-dollar market. |
| 2026-08-25 15:47:30 Moderna's stock saw a positive increase of over 5% after a key trading signal, indicating a strong performance in the market. |
| 2026-08-25 11:47:24 Investor sentiments surrounding the future potential of the cancer vaccine and its impact on stock valuations. |
| 2026-08-25 11:47:24 The potential of Moderna and Merck's personalized cancer vaccine to transform treatment and create significant market value. |